share_log

【持股变动报告】SBI投资报告增持Modalis Therapeutics(4883.JP)股份至5.38%

SBI Investment increases its stake in Modalis Therapeutics(4883.JP) to 5.38%

Futu News ·  Oct 2 16:04

On Oct 2, SBI Investment and related parties submitted the Change Report to Ministry of Finance. The report shows that SBI Investment and related parties increased their holdings in $Modalis Therapeutics (4883.JP)$, with their joint shareholding ratio up from 5.04% to 5.38%.

JPStockInsiderTradingAutoNewsSpider_nn_S100UH6P_1727856240_en-us

Source: Edinet Announcement

What is the 5% shareholding reporting system?

Shareholders with holding ratio exceeding 5% must submit a Large Shareholding Report within five business days from that day. If the holding ratio increases or decreases by 1% or more after submitting a Large Shareholding Report, the holder must submit a Change Report within five business days from that day.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment